Metformin-treated patients with diabetes showed a lower risk of intrahepatic cholangiocarcinoma compared with diabetes patients not taking the drug, researchers reported in Hepatology. Biliary tract disease, cirrhosis, diabetes and smoking were associated with an increased risk of ICC onset, researchers noted.
Lower ICC risk seen in diabetes patients on metformin
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan